Tetrahedral Framework Nucleic Acids Inhibit Aβ-mediated Ferroptosis and Ameliorate Cognitive and Synaptic Impairments in Alzheimer's Disease

Overview

Journal J Nanobiotechnology

Publisher Biomed Central

Specialty Biotechnology

Date 2024 Nov 7

PMID 39506721

Authors

Lu Tan

Jiazhao Xie

Chenqi Liao

Xiaoguang Li

Weiyun Zhang

Changchun Cai

Liming Cheng

Xiong Wang

Affiliations

Soon will be listed here.

Abstract

Background: Ferroptosis represents a nonapoptotic type of programmed cell death induced by excessive intracellular iron accumulation. Ferroptosis is an essential driver of the pathogenesis of Alzheimer's disease (AD). Tetrahedral framework nucleic acids (tFNAs) are a novel type of nanoparticle with superior antiapoptotic capacity and excellent biocompatibility. However, the effect of tFNAs on Aβ triggered ferroptosis, cognitive and synaptic impairments in AD remains unknown.

Methods: N2a cells were treated with Aβ combined with/without tFNAs. Cell viability and levels of Fe, lipid peroxidation, MDA, LDH, and GSH were examined. RNA sequencing was applied to explore dysregulated ferroptosis related genes. Seven-month-old APP/PS1 mice were intranasally administrated with tFNAs for two weeks. Fluorescence imaging was used to detect the tFNAs distribution in the brain. Novel object recognition (NOR) test followed by Morris water maze (MWM) was used to test the learning and memory performance of mice. Golgi staining, Western blot, and immunofluorescence staining were used to examine synaptic plasticity.

Results: tFNAs promoted cell viability and GSH levels, reduced the levels of Fe, lipid peroxidation, MDA, and LDH in N2a cells treated with Aβ. RNA sequencing revealed that tFNAs reversed the promotive effect of Aβ on ferroptosis driver Atf3 gene and suppressive effect on ferroptosis suppressors Rrm2 and Furin genes. Fluorescence imaging confirmed the brain infiltration of tFNAs. tFNAs rescued synaptic and memory impairments, and ferroptosis in seven-month-old APP/PS1 mice.

Conclusions: Collectively, tFNAs inhibited Aβ-mediated ferroptosis and ameliorated cognitive and synaptic impairments in AD mice. tFNAs may serve as novel option to deal with AD.

References

Alim I, Caulfield J, Chen Y, Swarup V, Geschwind D, Ivanova E . Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke. Cell. 2019; 177(5):1262-1279.e25. DOI: 10.1016/j.cell.2019.03.032. View

Yanamadala Y, Roy R, Williams A, Uppu N, Kim A, DeCoster M . Intranasal Delivery of Cell-Penetrating Therapeutic Peptide Enhances Brain Delivery, Reduces Inflammation, and Improves Neurologic Function in Moderate Traumatic Brain Injury. Pharmaceutics. 2024; 16(6). PMC: 11206831. DOI: 10.3390/pharmaceutics16060774. View

Nance E, Pun S, Saigal R, Sellers D . Drug delivery to the central nervous system. Nat Rev Mater. 2024; 7(4):314-331. PMC: 10923597. DOI: 10.1038/s41578-021-00394-w. View

Li Y, Yan J, Zhao Q, Zhang Y, Zhang Y . ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression. Front Pharmacol. 2022; 13:904314. PMC: 9537618. DOI: 10.3389/fphar.2022.904314. View

Raven E, Lu P, Tishler T, Heydari P, Bartzokis G . Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging. J Alzheimers Dis. 2013; 37(1):127-36. DOI: 10.3233/JAD-130209. View

Li L, Li W, Zheng X, Liu Q, Du Q, Lai Y . Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation. Mol Med. 2022; 28(1):11. PMC: 8800262. DOI: 10.1186/s10020-022-00442-3. View

Qiu Z, Zhang H, Xia M, Gu J, Guo K, Wang H . Programmed Death of Microglia in Alzheimer's Disease: Autophagy, Ferroptosis, and Pyroptosis. J Prev Alzheimers Dis. 2023; 10(1):95-103. DOI: 10.14283/jpad.2023.3. View

Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F . Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biol. 2017; 14:450-464. PMC: 5680523. DOI: 10.1016/j.redox.2017.10.014. View

Shao X, Ma W, Xie X, Li Q, Lin S, Zhang T . Neuroprotective Effect of Tetrahedral DNA Nanostructures in a Cell Model of Alzheimer's Disease. ACS Appl Mater Interfaces. 2018; 10(28):23682-23692. DOI: 10.1021/acsami.8b07827. View

10.

Hanson L, Fine J, Svitak A, Faltesek K . Intranasal administration of CNS therapeutics to awake mice. J Vis Exp. 2013; (74). PMC: 3653240. DOI: 10.3791/4440. View

11.

Tang J, Huang L, Deng J, Wang Y, Guo C, Peng X . Cognitive enhancement and neuroprotective effects of OABL, a sesquiterpene lactone in 5xFAD Alzheimer's disease mice model. Redox Biol. 2022; 50:102229. PMC: 8760418. DOI: 10.1016/j.redox.2022.102229. View

12.

Slyk Z, Stachowiak N, Malecki M . Recombinant Adeno-Associated Virus Vectors for Gene Therapy of the Central Nervous System: Delivery Routes and Clinical Aspects. Biomedicines. 2024; 12(7). PMC: 11274884. DOI: 10.3390/biomedicines12071523. View

13.

Dong S, Lu Y, Peng G, Li J, Li W, Li M . Furin inhibits epithelial cell injury and alleviates experimental colitis by activating the Nrf2-Gpx4 signaling pathway. Dig Liver Dis. 2021; 53(10):1276-1285. DOI: 10.1016/j.dld.2021.02.011. View

14.

Ward R, Zucca F, Duyn J, Crichton R, Zecca L . The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014; 13(10):1045-60. PMC: 5672917. DOI: 10.1016/S1474-4422(14)70117-6. View

15.

Khan A, Liu M, Khan M, Zhai G . Progress in brain targeting drug delivery system by nasal route. J Control Release. 2017; 268:364-389. DOI: 10.1016/j.jconrel.2017.09.001. View

16.

Zhang T, Tian T, Zhou R, Li S, Ma W, Zhang Y . Design, fabrication and applications of tetrahedral DNA nanostructure-based multifunctional complexes in drug delivery and biomedical treatment. Nat Protoc. 2020; 15(8):2728-2757. DOI: 10.1038/s41596-020-0355-z. View

17.

Zhao D, Yang K, Guo H, Zeng J, Wang S, Xu H . Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review. Biomed Pharmacother. 2023; 164:114312. DOI: 10.1016/j.biopha.2023.114312. View

18.

Peng L, Bestard-Lorigados I, Song W . The synapse as a treatment avenue for Alzheimer's Disease. Mol Psychiatry. 2022; 27(7):2940-2949. DOI: 10.1038/s41380-022-01565-z. View

19.

Bao W, Pang P, Zhou X, Hu F, Xiong W, Chen K . Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease. Cell Death Differ. 2021; 28(5):1548-1562. PMC: 8166828. DOI: 10.1038/s41418-020-00685-9. View

20.

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen C . Alzheimer's disease. Lancet. 2021; 397(10284):1577-1590. PMC: 8354300. DOI: 10.1016/S0140-6736(20)32205-4. View